Qianjiang Yongan Pharmaceutical Co (SZSE:002365) 3-Year EBITDA Growth Rate : -17.30% (As of Mar. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Qianjiang Yongan Pharmaceutical Co 3-Year EBITDA Growth Rate?

Qianjiang Yongan Pharmaceutical Co's EBITDA per Share for the three months ended in Mar. 2024 was ¥0.12.

During the past 12 months, Qianjiang Yongan Pharmaceutical Co's average EBITDA Per Share Growth Rate was -74.90% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -17.30% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -8.70% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 13.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Qianjiang Yongan Pharmaceutical Co was 60.80% per year. The lowest was -21.20% per year. And the median was -0.70% per year.

Competitive Comparison of Qianjiang Yongan Pharmaceutical Co's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Qianjiang Yongan Pharmaceutical Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Qianjiang Yongan Pharmaceutical Co's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Qianjiang Yongan Pharmaceutical Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Qianjiang Yongan Pharmaceutical Co's 3-Year EBITDA Growth Rate falls into.

Qianjiang Yongan Pharmaceutical Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Qianjiang Yongan Pharmaceutical Co (SZSE:002365) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Qianjiang Yongan Pharmaceutical Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Qianjiang Yongan Pharmaceutical Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Qianjiang Yongan Pharmaceutical Co (SZSE:002365) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Qianjiang Yongan Pharmaceutical Co Ltd (SZSE:002365) » Definitions » 3-Year EBITDA Growth Rate

Traded in Other Exchanges

N/A

Address

No. 2, Guangze Avenue, Qianjiang Economic Development Zone, Hubei Province, Wuhan, CHN, 433100

Website

http://www.chinataurine.com

Qianjiang Yongan Pharmaceutical Co Ltd is a China-based company principally involved in the manufacturing of taurine products. The company sells its products in China and other international countries.

Executives

Mei Song Lin	Executives
Wang Zhi Hua	Executives
Hong Ren Gui	Executives
Wu Yu Xi	Directors, executives
Dai Xiang Zhen	Executives
Wu Xiao Bo	Directors, executives
Luo Bai Neng	Executives
Ding Hong Li	Directors, executives
Fang Xi Quan	Executives
Li Shao Bo	Executives
Deng Yong Hong	Securities Affairs Representative
Dong Shi Hao	Executives
Wu Guo Sen	Supervisors
Lv Xin Wu	Executives
Chen Yong	Directors, executives

Qianjiang Yongan Pharmaceutical Co (SZSE:002365) Headlines

No Headlines